nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ABCB1—adrenal gland cancer	0.781	1	CbGaD
Ezetimibe—ANPEP—Metabolism of Angiotensinogen to Angiotensins—REN—adrenal gland cancer	0.0214	0.119	CbGpPWpGaD
Ezetimibe—UGT1A1—urine—adrenal gland cancer	0.0082	0.206	CbGeAlD
Ezetimibe—NPC1L1—Lipid and lipoprotein metabolism—PRKACA—adrenal gland cancer	0.00745	0.0415	CbGpPWpGaD
Ezetimibe—ABCG5—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00589	0.0328	CbGpPWpGaD
Ezetimibe—ABCG8—ABC-family proteins mediated transport—ABCB1—adrenal gland cancer	0.00584	0.0325	CbGpPWpGaD
Ezetimibe—ABCG8—Lipid and lipoprotein metabolism—PRKACA—adrenal gland cancer	0.00565	0.0315	CbGpPWpGaD
Ezetimibe—ANPEP—Peptide hormone metabolism—REN—adrenal gland cancer	0.00563	0.0314	CbGpPWpGaD
Ezetimibe—ABCG5—ABC-family proteins mediated transport—ABCB1—adrenal gland cancer	0.00562	0.0313	CbGpPWpGaD
Ezetimibe—ABCG5—Lipid and lipoprotein metabolism—PRKACA—adrenal gland cancer	0.00544	0.0303	CbGpPWpGaD
Ezetimibe—ABCG2—Abacavir transmembrane transport—ABCB1—adrenal gland cancer	0.00501	0.0279	CbGpPWpGaD
Ezetimibe—UGT2B7—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00499	0.0278	CbGpPWpGaD
Ezetimibe—ABCC3—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00499	0.0278	CbGpPWpGaD
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—IGF2—adrenal gland cancer	0.0041	0.0228	CbGpPWpGaD
Ezetimibe—UGT1A1—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00406	0.0226	CbGpPWpGaD
Ezetimibe—ABCC2—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00396	0.0221	CbGpPWpGaD
Ezetimibe—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00372	0.0207	CbGpPWpGaD
Ezetimibe—ABCC3—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.00371	0.0207	CbGpPWpGaD
Ezetimibe—SOAT1—adrenal cortex—adrenal gland cancer	0.0036	0.0905	CbGeAlD
Ezetimibe—ANPEP—adrenal cortex—adrenal gland cancer	0.00344	0.0866	CbGeAlD
Ezetimibe—SOAT1—gonad—adrenal gland cancer	0.00298	0.075	CbGeAlD
Ezetimibe—SOAT1—pituitary gland—adrenal gland cancer	0.00291	0.0731	CbGeAlD
Ezetimibe—ABCG2—Abacavir transport and metabolism—ABCB1—adrenal gland cancer	0.00288	0.016	CbGpPWpGaD
Ezetimibe—ANPEP—pituitary gland—adrenal gland cancer	0.00278	0.07	CbGeAlD
Ezetimibe—ABCC3—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00273	0.0152	CbGpPWpGaD
Ezetimibe—CYP3A4—urine—adrenal gland cancer	0.00263	0.0661	CbGeAlD
Ezetimibe—SOAT1—adrenal gland—adrenal gland cancer	0.0026	0.0653	CbGeAlD
Ezetimibe—ABCG2—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.00256	0.0143	CbGpPWpGaD
Ezetimibe—ANPEP—adrenal gland—adrenal gland cancer	0.00248	0.0625	CbGeAlD
Ezetimibe—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00217	0.0121	CbGpPWpGaD
Ezetimibe—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00203	0.0113	CbGpPWpGaD
Ezetimibe—UGT1A3—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00194	0.0108	CbGpPWpGaD
Ezetimibe—ANPEP—Peptide hormone metabolism—POMC—adrenal gland cancer	0.00187	0.0104	CbGpPWpGaD
Ezetimibe—ABCC3—adrenal cortex—adrenal gland cancer	0.00172	0.0432	CbGeAlD
Ezetimibe—ABCC3—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00165	0.00918	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—CDKN2A—adrenal gland cancer	0.00161	0.00899	CbGpPWpGaD
Ezetimibe—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00157	0.00874	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—PTGS2—adrenal gland cancer	0.00151	0.00841	CbGpPWpGaD
Ezetimibe—ABCC3—ABC-family proteins mediated transport—ABCB1—adrenal gland cancer	0.0015	0.00835	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00146	0.00813	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—SDHB—adrenal gland cancer	0.00135	0.00754	CbGpPWpGaD
Ezetimibe—UGT1A1—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00134	0.00746	CbGpPWpGaD
Ezetimibe—ANPEP—Peptide hormone metabolism—CTNNB1—adrenal gland cancer	0.00134	0.00745	CbGpPWpGaD
Ezetimibe—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00131	0.00727	CbGpPWpGaD
Ezetimibe—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00124	0.00693	CbGpPWpGaD
Ezetimibe—ABCC3—adrenal gland—adrenal gland cancer	0.00124	0.0311	CbGeAlD
Ezetimibe—ABCC2—ABC-family proteins mediated transport—ABCB1—adrenal gland cancer	0.00119	0.00662	CbGpPWpGaD
Ezetimibe—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00115	0.00639	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00111	0.00616	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00107	0.00593	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00107	0.00593	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—REN—adrenal gland cancer	0.00106	0.00592	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—SDHB—adrenal gland cancer	0.00103	0.00571	CbGpPWpGaD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.00102	0.00566	CbGpPWpGaD
Ezetimibe—ABCG2—adrenal cortex—adrenal gland cancer	0.001	0.0251	CbGeAlD
Ezetimibe—ABCC2—adrenal gland—adrenal gland cancer	0.00099	0.0249	CbGeAlD
Ezetimibe—ABCG5—Metabolism—SDHB—adrenal gland cancer	0.000987	0.0055	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—RRM1—adrenal gland cancer	0.000872	0.00486	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—SDHD—adrenal gland cancer	0.000872	0.00486	CbGpPWpGaD
Ezetimibe—ABCG2—pituitary gland—adrenal gland cancer	0.000808	0.0203	CbGeAlD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—adrenal gland cancer	0.000808	0.0045	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000807	0.0045	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000777	0.00433	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000768	0.00428	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000739	0.00412	CbGpPWpGaD
Ezetimibe—ABCG2—adrenal gland—adrenal gland cancer	0.000722	0.0182	CbGeAlD
Ezetimibe—ABCG8—Metabolism—SDHD—adrenal gland cancer	0.000661	0.00368	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—RRM1—adrenal gland cancer	0.000661	0.00368	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—MED12—adrenal gland cancer	0.00065	0.00362	CbGpPWpGaD
Ezetimibe—UGT2B15—Biological oxidations—POMC—adrenal gland cancer	0.000646	0.0036	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—ABCB1—adrenal gland cancer	0.000636	0.00354	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—SDHD—adrenal gland cancer	0.000636	0.00354	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—RRM1—adrenal gland cancer	0.000636	0.00354	CbGpPWpGaD
Ezetimibe—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.000627	0.0035	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000622	0.00347	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000611	0.0034	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000599	0.00334	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000588	0.00327	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000581	0.00324	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—SDHB—adrenal gland cancer	0.000578	0.00322	CbGpPWpGaD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.000562	0.00313	CbGpPWpGaD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000549	0.00306	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000544	0.00303	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—IGF2—adrenal gland cancer	0.00053	0.00295	CbGpPWpGaD
Ezetimibe—ABCC3—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.000523	0.00292	CbGpPWpGaD
Ezetimibe—ABCB1—adrenal cortex—adrenal gland cancer	0.000493	0.0124	CbGeAlD
Ezetimibe—ABCG8—Metabolism—MED12—adrenal gland cancer	0.000493	0.00275	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PRKACA—adrenal gland cancer	0.000474	0.00264	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—MED12—adrenal gland cancer	0.000474	0.00264	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000464	0.00258	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000441	0.00245	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000424	0.00236	CbGpPWpGaD
Ezetimibe—ABCB1—gonad—adrenal gland cancer	0.000408	0.0103	CbGeAlD
Ezetimibe—ABCB1—pituitary gland—adrenal gland cancer	0.000398	0.01	CbGeAlD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.000388	0.00216	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—GNAS—adrenal gland cancer	0.000385	0.00214	CbGpPWpGaD
Ezetimibe—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000378	0.00211	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—ABCB1—adrenal gland cancer	0.000377	0.0021	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—SDHD—adrenal gland cancer	0.000372	0.00207	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—RRM1—adrenal gland cancer	0.000372	0.00207	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000366	0.00204	CbGpPWpGaD
Ezetimibe—ABCG2—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.000361	0.00201	CbGpPWpGaD
Ezetimibe—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00036	0.00201	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PRKACA—adrenal gland cancer	0.00036	0.002	CbGpPWpGaD
Ezetimibe—ABCB1—adrenal gland—adrenal gland cancer	0.000356	0.00895	CbGeAlD
Ezetimibe—ANPEP—Metabolism of proteins—POMC—adrenal gland cancer	0.000354	0.00197	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000351	0.00196	CbGpPWpGaD
Ezetimibe—UGT1A3—Biological oxidations—POMC—adrenal gland cancer	0.000346	0.00193	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PRKACA—adrenal gland cancer	0.000346	0.00193	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00034	0.00189	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000338	0.00188	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—SDHB—adrenal gland cancer	0.000309	0.00172	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000294	0.00164	CbGpPWpGaD
Ezetimibe—UGT2B7—Biological oxidations—POMC—adrenal gland cancer	0.000294	0.00164	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—GNAS—adrenal gland cancer	0.000291	0.00162	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—ABCB1—adrenal gland cancer	0.000286	0.00159	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000284	0.00158	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GNAS—adrenal gland cancer	0.000281	0.00156	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—MED12—adrenal gland cancer	0.000278	0.00155	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—ABCB1—adrenal gland cancer	0.000275	0.00153	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SDHB—adrenal gland cancer	0.000263	0.00147	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SDHB—adrenal gland cancer	0.000263	0.00147	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—POMC—adrenal gland cancer	0.000259	0.00144	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—CTNNB1—adrenal gland cancer	0.000253	0.00141	CbGpPWpGaD
Ezetimibe—UGT1A1—Biological oxidations—POMC—adrenal gland cancer	0.000239	0.00133	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SDHB—adrenal gland cancer	0.000214	0.00119	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000211	0.00118	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00021	0.00117	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000207	0.00115	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PTGS2—adrenal gland cancer	0.000207	0.00115	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PRKACA—adrenal gland cancer	0.000203	0.00113	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—RRM1—adrenal gland cancer	0.000199	0.00111	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—SDHD—adrenal gland cancer	0.000199	0.00111	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000197	0.0011	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—POMC—adrenal gland cancer	0.000196	0.00109	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SDHB—adrenal gland cancer	0.000196	0.00109	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—POMC—adrenal gland cancer	0.000189	0.00105	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SDHB—adrenal gland cancer	0.000181	0.00101	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—RRM1—adrenal gland cancer	0.00017	0.000945	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SDHD—adrenal gland cancer	0.00017	0.000945	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—RRM1—adrenal gland cancer	0.00017	0.000945	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SDHD—adrenal gland cancer	0.00017	0.000945	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GNAS—adrenal gland cancer	0.000164	0.000914	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ABCB1—adrenal gland cancer	0.000161	0.000897	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00016	0.000889	CbGpPWpGaD
Ezetimibe—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000157	0.000874	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000157	0.000872	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PTGS2—adrenal gland cancer	0.000156	0.000872	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000156	0.00087	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000154	0.000859	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PTGS2—adrenal gland cancer	0.000151	0.000839	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—MED12—adrenal gland cancer	0.000149	0.000828	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000147	0.000817	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SDHD—adrenal gland cancer	0.000138	0.000768	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—RRM1—adrenal gland cancer	0.000138	0.000768	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000136	0.000756	CbGpPWpGaD
Ezetimibe—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000127	0.000709	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000127	0.000705	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—MED12—adrenal gland cancer	0.000126	0.000704	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—MED12—adrenal gland cancer	0.000126	0.000704	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SDHD—adrenal gland cancer	0.000126	0.000703	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—RRM1—adrenal gland cancer	0.000126	0.000703	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000124	0.000692	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000119	0.000662	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—RRM1—adrenal gland cancer	0.000117	0.000651	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SDHD—adrenal gland cancer	0.000117	0.000651	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000117	0.00065	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000113	0.00063	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—POMC—adrenal gland cancer	0.000111	0.000616	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00011	0.000613	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000109	0.00061	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PRKACA—adrenal gland cancer	0.000108	0.000604	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000108	0.000602	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—MED12—adrenal gland cancer	0.000103	0.000572	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SDHB—adrenal gland cancer	9.81e-05	0.000546	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—MED12—adrenal gland cancer	9.41e-05	0.000524	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PRKACA—adrenal gland cancer	9.22e-05	0.000514	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PRKACA—adrenal gland cancer	9.22e-05	0.000514	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	9.01e-05	0.000502	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTGS2—adrenal gland cancer	8.81e-05	0.000491	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GNAS—adrenal gland cancer	8.79e-05	0.00049	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—MED12—adrenal gland cancer	8.72e-05	0.000486	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ABCB1—adrenal gland cancer	8.63e-05	0.000481	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	8.42e-05	0.000469	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	8.05e-05	0.000448	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PRKACA—adrenal gland cancer	7.5e-05	0.000418	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GNAS—adrenal gland cancer	7.48e-05	0.000416	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GNAS—adrenal gland cancer	7.48e-05	0.000416	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	7.34e-05	0.000409	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ABCB1—adrenal gland cancer	7.34e-05	0.000409	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ABCB1—adrenal gland cancer	7.34e-05	0.000409	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	7.2e-05	0.000401	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PRKACA—adrenal gland cancer	6.87e-05	0.000383	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	6.76e-05	0.000377	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.71e-05	0.000374	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PRKACA—adrenal gland cancer	6.36e-05	0.000354	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SDHD—adrenal gland cancer	6.32e-05	0.000352	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—RRM1—adrenal gland cancer	6.32e-05	0.000352	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GNAS—adrenal gland cancer	6.07e-05	0.000338	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SDHB—adrenal gland cancer	6.04e-05	0.000337	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ABCB1—adrenal gland cancer	5.96e-05	0.000332	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.95e-05	0.000331	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—POMC—adrenal gland cancer	5.92e-05	0.00033	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	5.7e-05	0.000318	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GNAS—adrenal gland cancer	5.57e-05	0.00031	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ABCB1—adrenal gland cancer	5.46e-05	0.000304	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GNAS—adrenal gland cancer	5.15e-05	0.000287	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ABCB1—adrenal gland cancer	5.06e-05	0.000282	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—POMC—adrenal gland cancer	5.03e-05	0.00028	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—POMC—adrenal gland cancer	5.03e-05	0.00028	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	4.79e-05	0.000267	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS2—adrenal gland cancer	4.72e-05	0.000263	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MED12—adrenal gland cancer	4.71e-05	0.000263	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—POMC—adrenal gland cancer	4.09e-05	0.000228	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS2—adrenal gland cancer	4.01e-05	0.000224	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS2—adrenal gland cancer	4.01e-05	0.000224	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SDHD—adrenal gland cancer	3.89e-05	0.000217	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—RRM1—adrenal gland cancer	3.89e-05	0.000217	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—POMC—adrenal gland cancer	3.75e-05	0.000209	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—POMC—adrenal gland cancer	3.47e-05	0.000193	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PRKACA—adrenal gland cancer	3.44e-05	0.000192	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS2—adrenal gland cancer	3.26e-05	0.000182	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS2—adrenal gland cancer	2.99e-05	0.000167	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MED12—adrenal gland cancer	2.9e-05	0.000162	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.79e-05	0.000155	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS2—adrenal gland cancer	2.77e-05	0.000154	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	2.12e-05	0.000118	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—POMC—adrenal gland cancer	1.88e-05	0.000105	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.72e-05	9.56e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.68e-05	9.39e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.5e-05	8.34e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—POMC—adrenal gland cancer	1.16e-05	6.44e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	9.22e-06	5.14e-05	CbGpPWpGaD
